F. Higashitani

Characterization of a new plasmid-mediated extended-spectrum beta-lactamase from Serratia marcescens.

C. Kunugita, F. Higashitani, A. Hyodo, 1995, The Journal of antibiotics.

Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosa.

F. Higashitani, A. Hyodo, K. Nishida, 1997, Chemotherapy.

In Vitro and In Vivo Activities of Syn2190, a Novel β-Lactamase Inhibitor

R. Micetich, K. Atchison, H. Atwal, 1999, Antimicrobial Agents and Chemotherapy.

Effects of tazobactam on the frequency of the emergence of resistant strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (beta-lactamase derepressed mutants).

F. Higashitani, A. Hyodo, M. Inoue, 1995, The Journal of antibiotics.

Synthesis and Antibacterial Activity of 7-Hydrazinoquinolones.

Rajeshwar Singh, R. Micetich, M. P. Singh, 1998 .

In Vitro and In Vivo Activities of Syn2836, Syn2869, Syn2903, and Syn2921: New Series of Triazole Antifungal Agents

R. Micetich, H. Montaseri, H. Atwal, 2001, Antimicrobial Agents and Chemotherapy.

Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin.

S. Mitsuhashi, M. Inoue, N. Ishida, 1990, The Journal of antimicrobial chemotherapy.